[EN] COMPOSITIONS AND METHODS FOR TREATING TOXOPLASMOSIS. CRYPTOSPORIDIOSIS AND OTHER APICOMPLEXAN PROTOZOAN RELATED DISEASES<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR TRAITER LA TOXOPLASMOSE, LA CRYPTOSPORIDIOSE ET D'AUTRES MALADIES ASSOCIÉES AUX PROTOZOAIRES APICOMPLEXA
申请人:UNIV WASHINGTON
公开号:WO2011094628A1
公开(公告)日:2011-08-04
Compositions and methods for the treatment of toxoplasmosis-, caused by the infectious eukaryotic parasite Toxoplasma gondii (T, gondii) and for the treatment of ciyptosporidiosis, caused by the infectious eukaryotic parasites Cryptosporidium parvum (C parvuai) and Cnγtosporidium homimus (C. hominus) are described. In particular, the present disclosure is directed to compositions and methods for inhibiting either T. gondii calcium dependent protein kinases (TgCDPKs) or C. parvum and C. hominus calcium dependent protein kinases (CpDPKS) using pyrazolopyriinidine and/or imidazo[l,5-a]pyraziαe inhibitors, of the formula.(I), wherein the variables X. Y, Z, L. R1. and R3 are defined herein.
本文描述了用于治疗由感染性真核寄生虫弓形虫(T. gondii)引起的弓形虫病和用于治疗由感染性真核寄生虫隐孢子虫(C. parvum)和人隐孢子虫(C. hominus)引起的隐孢子虫病的组合物和方法。具体而言,本公开涉及使用吡唑吡啶啉和/或咪唑[1,5-a]吡嗪类抑制剂来抑制T. gondii钙依赖蛋白激酶(TgCDPKs)或C. parvum和C. hominus钙依赖蛋白激酶(CpDPKS)的组合物和方法,其化学式为(I),其中变量X、Y、Z、L、R1和R3在此处定义。